vs

Side-by-side financial comparison of Agilent Technologies (A) and AUTOLIV INC (ALV). Click either name above to swap in a different company.

AUTOLIV INC is the larger business by last-quarter revenue ($2.8B vs $1.8B, roughly 1.6× Agilent Technologies). Agilent Technologies runs the higher net margin — 17.0% vs 8.0%, a 8.9% gap on every dollar of revenue. On growth, AUTOLIV INC posted the faster year-over-year revenue change (7.7% vs 7.0%). AUTOLIV INC produced more free cash flow last quarter ($426.0M vs $175.0M). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs 3.8%).

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...

Autoliv is an American-Swedish automotive safety supplier headquartered in Stockholm, Sweden, and incorporated in Delaware, United States as Autoliv, Inc. It is the world’s largest automotive safety system supplier, producing systems such as airbags, seatbelts, and steering wheels for automotive manufacturers. Autoliv's name combines auto for automobiles, and "liv" {‘li:v} the Swedish word for "life".

A vs ALV — Head-to-Head

Bigger by revenue
ALV
ALV
1.6× larger
ALV
$2.8B
$1.8B
A
Growing faster (revenue YoY)
ALV
ALV
+0.8% gap
ALV
7.7%
7.0%
A
Higher net margin
A
A
8.9% more per $
A
17.0%
8.0%
ALV
More free cash flow
ALV
ALV
$251.0M more FCF
ALV
$426.0M
$175.0M
A
Faster 2-yr revenue CAGR
A
A
Annualised
A
6.9%
3.8%
ALV

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
A
A
ALV
ALV
Revenue
$1.8B
$2.8B
Net Profit
$305.0M
$226.0M
Gross Margin
52.6%
20.3%
Operating Margin
19.6%
11.4%
Net Margin
17.0%
8.0%
Revenue YoY
7.0%
7.7%
Net Profit YoY
-4.1%
-7.4%
EPS (diluted)
$1.07
$2.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
A
A
ALV
ALV
Q1 26
$1.8B
Q4 25
$1.9B
$2.8B
Q3 25
$1.7B
$2.7B
Q2 25
$1.7B
$2.7B
Q1 25
$1.7B
$2.6B
Q4 24
$1.7B
$2.6B
Q3 24
$1.6B
$2.6B
Q2 24
$1.6B
$2.6B
Net Profit
A
A
ALV
ALV
Q1 26
$305.0M
Q4 25
$434.0M
$226.0M
Q3 25
$336.0M
$175.0M
Q2 25
$215.0M
$167.0M
Q1 25
$318.0M
$167.0M
Q4 24
$351.0M
$244.0M
Q3 24
$282.0M
$138.0M
Q2 24
$308.0M
$138.0M
Gross Margin
A
A
ALV
ALV
Q1 26
52.6%
Q4 25
53.2%
20.3%
Q3 25
51.1%
19.3%
Q2 25
51.9%
18.5%
Q1 25
53.5%
18.5%
Q4 24
53.9%
21.0%
Q3 24
54.2%
18.0%
Q2 24
54.4%
18.2%
Operating Margin
A
A
ALV
ALV
Q1 26
19.6%
Q4 25
23.8%
11.4%
Q3 25
20.7%
9.9%
Q2 25
18.0%
9.1%
Q1 25
22.4%
9.9%
Q4 24
24.0%
13.5%
Q3 24
21.1%
8.8%
Q2 24
23.1%
7.9%
Net Margin
A
A
ALV
ALV
Q1 26
17.0%
Q4 25
23.3%
8.0%
Q3 25
19.3%
6.5%
Q2 25
12.9%
6.2%
Q1 25
18.9%
6.5%
Q4 24
20.6%
9.3%
Q3 24
17.9%
5.4%
Q2 24
19.6%
5.3%
EPS (diluted)
A
A
ALV
ALV
Q1 26
$1.07
Q4 25
$1.53
$2.97
Q3 25
$1.18
$2.28
Q2 25
$0.75
$2.16
Q1 25
$1.11
$2.14
Q4 24
$1.23
$3.07
Q3 24
$0.97
$1.74
Q2 24
$1.05
$1.71

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
A
A
ALV
ALV
Cash + ST InvestmentsLiquidity on hand
$1.8B
$604.0M
Total DebtLower is stronger
$3.0B
Stockholders' EquityBook value
$6.9B
$2.6B
Total Assets
$12.8B
$8.6B
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
A
A
ALV
ALV
Q1 26
$1.8B
Q4 25
$1.8B
$604.0M
Q3 25
$1.5B
$225.0M
Q2 25
$1.5B
$237.0M
Q1 25
$1.5B
$322.0M
Q4 24
$1.3B
$330.0M
Q3 24
$1.8B
$415.0M
Q2 24
$1.7B
$408.0M
Total Debt
A
A
ALV
ALV
Q1 26
$3.0B
Q4 25
$3.0B
Q3 25
$3.4B
Q2 25
$3.3B
Q1 25
$3.3B
Q4 24
$3.3B
Q3 24
$2.1B
Q2 24
$2.1B
Stockholders' Equity
A
A
ALV
ALV
Q1 26
$6.9B
Q4 25
$6.7B
$2.6B
Q3 25
$6.4B
$2.5B
Q2 25
$6.1B
$2.5B
Q1 25
$6.0B
$2.4B
Q4 24
$5.9B
$2.3B
Q3 24
$5.9B
$2.3B
Q2 24
$6.2B
$2.3B
Total Assets
A
A
ALV
ALV
Q1 26
$12.8B
Q4 25
$12.7B
$8.6B
Q3 25
$12.2B
$8.5B
Q2 25
$12.2B
$8.5B
Q1 25
$11.9B
$8.1B
Q4 24
$11.8B
$7.8B
Q3 24
$11.0B
$8.3B
Q2 24
$10.9B
$8.0B
Debt / Equity
A
A
ALV
ALV
Q1 26
0.44×
Q4 25
0.45×
Q3 25
0.53×
Q2 25
0.55×
Q1 25
0.56×
Q4 24
0.57×
Q3 24
0.36×
Q2 24
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
A
A
ALV
ALV
Operating Cash FlowLast quarter
$268.0M
$544.0M
Free Cash FlowOCF − Capex
$175.0M
$426.0M
FCF MarginFCF / Revenue
9.7%
15.1%
Capex IntensityCapex / Revenue
5.2%
4.2%
Cash ConversionOCF / Net Profit
0.88×
2.41×
TTM Free Cash FlowTrailing 4 quarters
$993.0M
$716.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
A
A
ALV
ALV
Q1 26
$268.0M
Q4 25
$545.0M
$544.0M
Q3 25
$362.0M
$258.0M
Q2 25
$221.0M
$278.0M
Q1 25
$431.0M
$77.0M
Q4 24
$481.0M
$420.0M
Q3 24
$452.0M
$177.0M
Q2 24
$333.0M
$340.0M
Free Cash Flow
A
A
ALV
ALV
Q1 26
$175.0M
Q4 25
$452.0M
$426.0M
Q3 25
$259.0M
$152.0M
Q2 25
$107.0M
$163.0M
Q1 25
$334.0M
$-25.0M
Q4 24
$388.0M
$281.0M
Q3 24
$360.0M
$31.0M
Q2 24
$230.0M
$186.0M
FCF Margin
A
A
ALV
ALV
Q1 26
9.7%
Q4 25
24.3%
15.1%
Q3 25
14.9%
5.6%
Q2 25
6.4%
6.0%
Q1 25
19.9%
-1.0%
Q4 24
22.8%
10.7%
Q3 24
22.8%
1.2%
Q2 24
14.6%
7.1%
Capex Intensity
A
A
ALV
ALV
Q1 26
5.2%
Q4 25
5.0%
4.2%
Q3 25
5.9%
3.9%
Q2 25
6.8%
4.2%
Q1 25
5.8%
4.0%
Q4 24
5.5%
5.3%
Q3 24
5.8%
5.7%
Q2 24
6.5%
5.9%
Cash Conversion
A
A
ALV
ALV
Q1 26
0.88×
Q4 25
1.26×
2.41×
Q3 25
1.08×
1.47×
Q2 25
1.03×
1.66×
Q1 25
1.36×
0.46×
Q4 24
1.37×
1.72×
Q3 24
1.60×
1.28×
Q2 24
1.08×
2.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

A
A

Service Other$525.0M29%
Chemicaland Energy Market$422.0M23%
Agilent Cross Lab$273.0M15%
Environmentaland Forensics Market$177.0M10%
Food Market$166.0M9%
Academiaand Government Market$130.0M7%
Applied Markets$98.0M5%

ALV
ALV

Segment breakdown not available.

Related Comparisons